ABVC Biopharma Inc (ABVC) — Net Asset Quality Index
ABVC Biopharma Inc (ABVC) has a Net Asset Quality Index of 65.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $19.73 Million minus total liabilities of $6.90 Million yields net assets of $12.83 Million. A higher index indicates a stronger, lower-leverage balance sheet. See ABVC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
ABVC Biopharma Inc Net Asset Quality Index Over Time (2002–2025)
This chart shows how ABVC Biopharma Inc's Net Asset Quality Index has evolved across 22 annual periods from 2002 to 2025. As of March 2026, the index stands at 65.0%, representing net assets of $12.83 Million against total assets of $19.73 Million USD. Explore ABVC Biopharma Inc (ABVC) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for ABVC Biopharma Inc (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for ABVC Biopharma Inc from 2002 to 2025, covering 22 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ABVC stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 63.1% | $13.30 Million | $21.06 Million | $7.76 Million | ▲ +53.5 pp |
| 2024 | 9.6% | $723.96K | $7.54 Million | $6.82 Million | ▼ -6.5 pp |
| 2023 | 16.1% | $1.25 Million | $7.78 Million | $6.53 Million | ▼ -25.9 pp |
| 2022 | 42.0% | $4.59 Million | $10.93 Million | $6.34 Million | ▼ -22.8 pp |
| 2021 | 64.8% | $8.87 Million | $13.70 Million | $4.83 Million | ▲ +25.3 pp |
| 2020 | 39.4% | $5.82 Million | $14.77 Million | $8.94 Million | ▲ +41.2 pp |
| 2019 | -1.8% | $-124.82K | $6.93 Million | $7.05 Million | ▲ +5970.2 pp |
| 2018 | -5972.0% | $-5.75 Million | $96.27K | $5.85 Million | ▼ -6009.2 pp |
| 2017 | 37.3% | $2.46 Million | $6.60 Million | $4.14 Million | ▲ +35003.5 pp |
| 2016 | -34966.2% | $-6.52 Million | $18.64K | $6.54 Million | ▼ -35008.9 pp |
| 2015 | 42.6% | $29.08K | $68.23K | $39.15K | ▼ -4.7 pp |
| 2014 | 47.3% | $30.56K | $64.59K | $34.03K | ▲ +443.6 pp |
| 2011 | -396.2% | $-1.46 Million | $369.40K | $1.83 Million | ▲ +622.3 pp |
| 2010 | -1018.5% | $-2.99 Million | $293.94K | $3.29 Million | ▼ -630.5 pp |
| 2009 | -388.0% | $-2.01 Million | $518.17K | $2.53 Million | ▼ -305.5 pp |
| 2008 | -82.5% | $-1.24 Million | $1.50 Million | $2.74 Million | ▼ -106.7 pp |
| 2007 | 24.1% | $290.29K | $1.20 Million | $913.84K | ▼ -15.8 pp |
| 2006 | 39.9% | $35.27K | $88.34K | $53.07K | ▼ -55.8 pp |
| 2005 | 95.7% | $60.67K | $63.40K | $2.72K | ▼ -1.0 pp |
| 2004 | 96.7% | $87.34K | $90.31K | $2.96K | ▲ +24.0 pp |
| 2003 | 72.7% | $80.00K | $110.00K | $30.00K | ▲ +47.7 pp |
| 2002 | 25.0% | $10.00K | $40.00K | $30.00K | — |